Dezeen Showroom: Spanish designer Josep Lluís Xuclà has designed a "magical" outdoor light for Marset, which creates the illusion of floating and glowing from within. Called Elipse, it consists of a ...

PHILADELPHIA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc., (NASDAQ: IPSC), an innovative clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived ...

EX103: A newly designed CD20×CD3 molecule in heavily pre-treated patients with B-cell non-Hodgkin lymphoma from a phase I/II trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I ...

– Data presented at 65th ASH Annual Meeting show CNTY-101 was generally well tolerated at Dose Level 1 (100 million cells) in a high-risk, heavily pretreated R/R B-cell lymphoma patient – – ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announces completion of enrollment in ...

Introducing the all new Elipse P100 source control mask. The Elipse P100 Respirator is not only a safe, reliable, compliant solution - it is also very cost-effective.

The medical device company is conducting a late-stage trial of a balloon meant to be swallowed to help patients lose weight. Allurion Technologies Inc. has raised $34 million as it conducts a ...

ZUMA-22: A phase 3, randomized controlled study of axicabtagene ciloleucel (axi-cel) versus standard-of-care therapy in patients with relapsed or refractory (R/R) follicular lymphoma (FL). This is an ...